We found a nonsignificant trend towards increased risk of metastasis with increasing doses of prediagnosis aspirin ( p for trend = 0.097).
← all excerpts
Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.
1
—
—